Emad Shash: Honored to Be Selected as Best Poster in the Supportive Care and Survivorship at ESMO 2026
Emad Shash/LinkedIn

Emad Shash: Honored to Be Selected as Best Poster in the Supportive Care and Survivorship at ESMO 2026

Emad Shash, Leading Cancer Researcher and Director at National Cancer Institute, Cairo University, shared a post on LinkedIn:

Allhamdoullah, I am truly honored and grateful that our poster, 605P, ‘Feasibility and Acceptability of a QR-Based Digital Medication Education Tool Integrated with Pharmacist Counseling for Breast Cancer Patients,’ was selected as Best Poster in the Supportive Care and Survivorship track at the ESMO Breast Cancer Congress.

My sincere thanks to the ESMO – European Society for Medical Oncology ESMO Breast Cancer Congress 2026 Scientific Committee for recognizing our work and for highlighting the importance of supportive care, patient education, and practical digital solutions in breast cancer care.

This project reflects a simple but important belief: patient education should not end when the counseling session ends. By integrating a QR-based Arabic medication education tool with pharmacist counseling, we aimed to help patients and caregivers revisit reliable medication information at home, improve understanding, and feel more confident throughout treatment.

This recognition belongs to the whole team:

Zeinab Abdelwhab, Esraa Abd El Fattah, Esraa Haider, Basma Nasr, Marwa Ali, Alia Abdelsalam, Ghada Emam, Reem Eid

I am especially proud that this work came from the Breast Cancer Comprehensive Center, National Cancer Institute, Cairo University, showing that scalable, low-cost, patient-centered innovation can come from real-world oncology practice in resource-limited settings.

Thank you to our patients and caregivers, whose needs, feedback, and daily challenges continue to guide our work.

This award is a motivation to keep building practical, supportive care solutions that improve patient understanding, engagement, and experience.”

Emad Shash

Other articles featuring Emad Shash on OncoDaily.